DRI Healthcare Trust (DHT-UN.TO)
Toronto · CAD · Healthcare · Drug Manufacturers - Specialty & Generic
CA$18.23 (-1.46%) as of
Key statistics
- Market cap
- 1.03B
- Forward P/E
- 4.61
- EPS (TTM)
- -1.14
- Dividend yield
- 3.29%
- 52-week range
- 14.77 – 19.75
- Beta
- 0.62
- Revenue (TTM)
- 200.72M
- Profit margin
- -21.95%
- Analyst target
- CA$24.07
- Volume
- 48.03k
About DRI Healthcare Trust
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Toronto, ON, Canada
- Employees
- 32
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.